Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Amended and Restated Certificate of Incorporation
- 3.3 Bylaws
- 4.2 Registration Rights Agreement
- 4.3 Amended and Restated Investors' Rights Agreement
- 4.4 Amendment to Amended and Restated Investors' Rights Agreement
- 4.5 Amended and Restated Stockholders' Agreement
- 4.6 Series B Convertible Preferred Stock Purchase Agreement
- 4.7 Amendment to Series B Convertible Preferred Stock Purchase Agreement
- 4.8 Form of Short Form Warrant
- 4.9 Form of Short Form Cashless Exercise Warrant
- 4.10 Form of Medium Form Warrant
- 4.11 Form of Long Form Warrant
- 4.12 Convertible Promissory Note
- 4.13 Convertible Promissory Note
- 10.1 2008 Stock Option Plan
- 10.2 Form of Notice of Stock Option Grant
- 10.3 Form of Stock Option Grant Agreement
- 10.4 Form of Exercise Notice and Restricted Stock Purchase Agreement
- 10.5 2011 Equity Compensation Plan
- 10.6 Form of Stock Option Grant Agreement
- 10.7 Form of Indemnification Agreement
- 10.8 Consulting Agreement Between Cancer Genetics, Inc. and TSG, LLC
- 10.9 Medical Director Agreement
- 10.10 Employment Agreement Between Cancer Genetics, Inc. and Louis J. Maione
- 10.11 Consulting Agreement Between Cancer Genetics, Inc. and Louis Malone
- 10.12 Termination Agreement
- 10.13 Consulting Agreement Between Cancer Genetics, Inc. and Edmund Cannon
- 10.14 Consulting Agreement Between Cancer Genetics, Inc. and Andrew Pecora
- 10.15 Consulting Agreement Between Cancer Genetics, Inc. and R.S.K. Chaganti
- 10.16 Consulting Ageement Between Cancer Genetics, Inc. and TSG, LLC
- 10.21 Credit Agreement Between Cancer Genetics, Inc. and Wells Fargo Bank N.a.
- 10.22 Security Agreement Between Cancer Genetics, Inc and Wells Fargo Bank N.a.
- 10.23 First Addendum to Credit Agreement
- 10.24 Second Addendum to Credit Agreement
- 10.25 Third Addendum to Credit Agreement
- 10.26 Fourth Addendum to Credit Agreement
- 10.27 Fifth Addendum to Credit Agreement
- 10.28 Credit Agreement Between Cancer Genetics, Inc. and Dam Holdings, LLC
- 10.29 Inter-creditor Agreement
- 10.30 General Business Security Agreement
- 10.31 Promissory Note Issued by Cancer Genetics, Inc.
- 10.32 Sixth Credit Agreement
- 10.35 Affiliation Agreement
- 21.1 Subsidiaries of Cancer Genetics, Inc
- 23.1 Consent of Mcgladrey & Pullen, LLP
VYNT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-1 of Cancer Genetics, Inc. and subsidiary of our report dated December 30, 2011, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
/s/ McGladrey & Pullen, LLP |
Des Moines, Iowa |
December 30, 2011 |